IP Library Granted Patent US 8,530,622
Granted Patent B2
US 8,530,622 · App. 13/262,305 · Granted Sep 10, 2013

Proteasome-activating anti-aging peptides and compositions containing same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,530,622
App. No.
13/262,305
Granted
Sep 10, 2013
Kind
B2
Abstract

The present invention relates to peptidic compounds of general formula (I): R 1 —X 1 —X 2 -Asp-Cys-Arg-X 3 —X 4 -(AA) p -R 2. In addition, the present invention relates to, on the one hand, a cosmetic or pharmaceutical composition comprising at least one peptide of general formula (I), in a cosmetically or pharmaceutically acceptable medium and, on the other hand, its utilization to prevent or treat the cutaneous signs of aging and photo-aging and to protect the skin from aggressions due to UV radiation. Lastly, the invention applies to a cosmetic treatment process intended to prevent and/or combat the cutaneous signs of aging and photo aging.

Claims (48)

1. A peptidic compound selected from the group consisting of:

(SEQ ID NO. 2)

Asp-Cys-Arg-Lys;

(SEQ ID NO. 3)

Glu-Leu-Asp-Cys-Arg-Lys-NH 2 ;

(SEQ ID NO. 4)

Ser-Asp-Cys-Arg-His-Pro; 

and

(SEQ ID NO. 5)

Arg-Asp-Cys-Arg-Arg-Phe-NH 2 .

2. A cosmetic composition comprising a peptidic compound selected from the group consisting of:

(SEQ ID NO. 2)

Asp-Cys-Arg-Lys;

(SEQ ID NO. 3)

Glu-Leu-Asp-Cys-Arg-Lys-NH 2 ;

(SEQ ID NO. 4)

Ser-Asp-Cys-Arg-His-Pro;

and

(SEQ ID NO. 5)

Arg-Asp-Cys-Arg-Arg-Phe-NH 2 .

3. The composition according to claim 2 , characterized in that the composition is present in a form suitable for topical application comprising a cosmetically acceptable medium.

4. The composition according to claim 2 , characterized in that said peptidic compound is present in the composition at a concentration of between approximately 0.0005 and 500 ppm.

5. The composition according to claim 2 , characterized in that said peptidic compound is solubilized in one or more solvents selected from the group consisting of water, glycerol, ethanol, propylene glycol, butylene glycol, dipropylene glycol, ethoxylated or propoxylated diethylene glycols, cyclic polyols, white petroleum jelly, vegetable oil, and combinations thereof.

6. The composition according to claim 2 , further comprising at least one active principle promoting the action of said peptidic compound.

7. The composition according to claim 6 , wherein said active principle promotes activity in the field of anti-wrinkles

8. The composition according to claim 6 , characterized in that said active principle is selected from the group consisting of vitamins, phytosterols, flavonoids, DHEA and/or one of its precursors or one of its chemical or biological derivatives, a metalloproteinase inhibitor, and a retinoid.

9. The composition according to claim 2 , characterized in that said peptidic compound is present in the composition at a concentration of between 0.01 and 5 ppm.

10. The composition according to claim 7 , wherein said active principle presenting activity in the field of anti-wrinkles in chosen among an antiradical or antioxidant agent, or an agent stimulating the synthesis of dermal macromolecules, or else an agent stimulating energy metabolism.

11. A method of treating the cutaneous signs of aging and photo-aging, the method comprising:

providing a composition comprising an effective quantity of a peptidic compound of selected from the group consisting of:

(SEQ ID No. 1)

Asp-Cys-Arg-NH 2 ;

(SEQ ID No. 2)

Asp-Cys-Arg-Lys;

(SEQ ID No. 3)

Glu-Leu-Asp-Cys-Arg-Lys-NH 2 ;

(SEQ ID No. 4)

Ser-Asp-Cys-Arg-His-Pro;

(SEQ ID No. 5)

Arg-Asp-Cys-Arg-Arg-Phe-NH 2 ;

in an acceptable medium; and

topically applying the composition to the skin or keratinous appendages to be treated.

12. The method of claim 11 , characterized in that signs of aging is understood to refer to wrinkles, deep and coarse wrinkles, fine lines, scratches, sagging cutaneous and subcutaneous tissues, the loss of skin elasticity and atonia, the loss of skin firmness and tonicity, and skin atrophy.

13. The method of claim 11 , characterized in that said composition activates cell renewal and thoroughly cleans the cells.

14. The method of claim 11 , characterized in that said composition enables the skin to be protected from aggressions due to UV radiation.

15. The method of claim 11 , wherein the cosmetic composition increases proteasome activity and improves degradation by proteasome of damaged proteins.

16. The method of claim 11 , wherein the composition is a cosmetic composition and the acceptable medium is a cosmetically acceptable medium.

17. The method of claim 16 , characterized in that the cosmetic composition is applied before bedtime so as to clean the skin during the cell renewal cycle.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CONVERSION Recorded Jan 30, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 041556/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2012
From: DAL FARRA, CLAUDE; DOMLOGE, NOUHA; BOTTO, JEAN-MARIE
To: ISP INVESTMENTS INC.
Reel/Frame 028867/0517 →